Selective fluorescence probes for dipeptidyl peptidase activity-fibroblast activation protein and dipeptidyl peptidase IV.

TitleSelective fluorescence probes for dipeptidyl peptidase activity-fibroblast activation protein and dipeptidyl peptidase IV.
Publication TypeJournal Article
Year of Publication2007
AuthorsLai KSiew, Ho N-H, Cheng JD, Tung C-H
JournalBioconjug Chem
Volume18
Issue4
Pagination1246-50
Date Published2007 Jul-Aug
ISSN1043-1802
KeywordsAnimals, Biosensing Techniques, Cell Line, Dipeptidyl Peptidase 4, Endopeptidases, Fluorescent Dyes, Gelatinases, Humans, Membrane Proteins, Mice, Oligopeptides, Oxazines, Recombinant Proteins, Serine Endopeptidases, Transfection
Abstract

Development of suitable tools to assess enzyme activity directly from their complex cellular environment has a dramatic impact on understanding the functional roles of proteins as well as on the discovery of new drugs. In this study, a novel fluorescence-based chemosensor strategy for the direct readout of dipeptidase activities within intact living cells is described. Selective activity-based probes were designed to sense two important type II transmembrane serine proteases, fibroblast activation protein (FAP) and dipeptidyl peptidase IV (DPP-IV). These serine proteases have been implicated in diverse cellular activities, including blood coagulation, digestion, immune responses, wound healing, tumor growth, tumor invasion, and metastasis. Here, we validated that Ac-GPGP-2SBPO and GPGP-2SBPO probes are excellent reporters of both proteolytic activities. Furthermore, the novel probes can differentiate between FAP and DPP-IV proteolytic activities in cellular assay. Potentially, this assay platform is immediately useful for novel drug discovery.

DOI10.1021/bc0603586
Alternate JournalBioconjug Chem
PubMed ID17489551
PubMed Central IDPMC2562575
Grant ListCA090468 / CA / NCI NIH HHS / United States
R01 CA099385 / CA / NCI NIH HHS / United States
R01 CA099385-04 / CA / NCI NIH HHS / United States
R21 CA114149-01 / CA / NCI NIH HHS / United States
R33 CA114149 / CA / NCI NIH HHS / United States
P50 CA086355 / CA / NCI NIH HHS / United States
CA86355 / CA / NCI NIH HHS / United States
R21 CA103991 / CA / NCI NIH HHS / United States
CA114149 / CA / NCI NIH HHS / United States
CA006927 / CA / NCI NIH HHS / United States
K08 CA090468 / CA / NCI NIH HHS / United States
R33 CA114149-03 / CA / NCI NIH HHS / United States
CA103991 / CA / NCI NIH HHS / United States
P30 CA006927 / CA / NCI NIH HHS / United States
R33 CA114149-02 / CA / NCI NIH HHS / United States
CA099385 / CA / NCI NIH HHS / United States
R21 CA114149 / CA / NCI NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065